Janus Henderson Global Life Sciences Fund I2 USD
IE0002141913
Janus Henderson Global Life Sciences Fund I2 USD/ IE0002141913 /
NAV07/11/2024 |
Diferencia+0.2400 |
Tipo de beneficio |
Enfoque de la inversión |
Sociedad de fondos |
70.2900USD |
+0.34% |
reinvestment |
Equity
Worldwide
|
Janus Henderson Inv. ▶ |
Estrategia de inversión
The Fund aims to provide capital growth over the long term. Performance target: To outperform the MSCI World Health Care Index by at least 2% per annum, before the deduction of charges, over any 5 year period.
The Fund invests at least 80% in shares (also known as equities) of companies, of any size, including smaller capitalisation companies, with a life sciences orientation, in any country. Up to 20% may be invested in developing markets. The Fund may also invest in other assets including cash and money market instruments. The Sub-Investment Adviser may use derivatives (complex financial instruments) to reduce risk, to manage the Fund more efficiently, or to generate additional capital or income for the Fund. The Fund is actively managed with reference to the MSCI World Health Care Index, which is broadly
Objetivo de inversión
The Fund aims to provide capital growth over the long term. Performance target: To outperform the MSCI World Health Care Index by at least 2% per annum, before the deduction of charges, over any 5 year period.
Datos maestros
Tipo de beneficio: |
reinvestment |
Categoría de fondos: |
Equity |
Región: |
Worldwide |
Sucursal: |
Sector Health / Pharma |
Punto de referencia: |
MSCI World Health Care Index |
Inicio del año fiscal: |
01/01 |
Última distribución: |
- |
Banco depositario: |
J.P. Morgan SE, Dublin Branch |
País de origen: |
Ireland |
Permiso de distribución: |
Austria, Germany, Switzerland, United Kingdom |
Gestor de fondo: |
Andy Acker, Daniel Lyons |
Volumen de fondo: |
4.26 mil millones
USD
|
Fecha de fundación: |
31/03/2000 |
Enfoque de la inversión: |
- |
Condiciones
Recargo de emisión: |
2.00% |
Max. Comisión de administración: |
1.50% |
Inversión mínima: |
1,000,000.00 USD |
Deposit fees: |
- |
Cargo por amortización: |
0.00% |
Prospecto simplificado: |
Descargar (Versión para imprimir) |
Sociedad de fondos
Fondos de empresa: |
Janus Henderson Inv. |
Dirección: |
201 Bishopsgate, EC2M 3AE, London |
País: |
United Kingdom |
Internet: |
www.janushenderson.com/
|
Activos
Stocks |
|
99.33% |
Cash |
|
0.66% |
Otros |
|
0.01% |
Países
United States of America |
|
73.77% |
Denmark |
|
5.89% |
United Kingdom |
|
3.99% |
Switzerland |
|
3.48% |
France |
|
2.76% |
Ireland |
|
2.37% |
Netherlands |
|
1.94% |
Virgin Islands (British) |
|
1.03% |
Japan |
|
0.68% |
Israel |
|
0.66% |
Cash |
|
0.66% |
China |
|
0.59% |
Cayman Islands |
|
0.56% |
Canada |
|
0.22% |
Otros |
|
1.40% |
Sucursales
Pharma/Biotechnology |
|
63.83% |
Healthcare services |
|
16.62% |
Healthcare appliances |
|
15.43% |
Parma, wholesale |
|
1.45% |
Cash |
|
0.66% |
Gesundheitswesen/ Informationstechnologie |
|
0.61% |
Otros |
|
1.40% |